Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Arnaud Pouchon, Rayan Nasserdine, Clément Dondé, Antoine Bertrand, Mircea Polosan & Stéphanie Bioulac. (2023) A systematic review of pharmacotherapy for attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders. Expert Opinion on Pharmacotherapy 24:13, pages 1497-1509.
Read now
Read now
Jose C. Appolinario, Antonio E. Nardi & Susan L. McElroy. (2019) Investigational drugs for the treatment of binge eating disorder (BED): an update. Expert Opinion on Investigational Drugs 28:12, pages 1081-1094.
Read now
Read now
Articles from other publishers (24)
Di Fu, Hong-Li Guo, Ya-Hui Hu, Wei-Rong Fang, Qian-Qi Liu, Jing Xu, Dan-Dan Wu & Feng Chen. (2023) Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence. European Journal of Clinical Pharmacology.
Crossref
Crossref
S.Yu. Surushkina & L.S. Chutko. (2023) Pharmacotherapy and psychotherapy of children with attention deficit hyperactivity disorder. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 123:2, pages 21.
Crossref
Crossref
AK Chigome, JC Meyer & N Schellack. (2022) The management of attention-deficit hyperactivity disorder in children: updated 2022. South African General Practitioner 3:4, pages 121-131.
Crossref
Crossref
Mohamed Adil Shah Khoodoruth, Sami Ouanes & Yasser Saeed Khan. (2022) A systematic review of the use of atomoxetine for management of comorbid anxiety disorders in children and adolescents with attention-deficit hyperactivity disorder. Research in Developmental Disabilities 128, pages 104275.
Crossref
Crossref
Keith O. Plowden, Timothy Legg & Dana Wiley. (2022) Attention deficit/hyperactivity disorder in adults: A case study. Archives of Psychiatric Nursing 38, pages 29-35.
Crossref
Crossref
Andrew J. Cutler, Gregory W. Mattingly, Rakesh Jain & Welton O’Neal. (2020) Current and future nonstimulants in the treatment of pediatric ADHD: monoamine reuptake inhibitors, receptor modulators, and multimodal agents. CNS Spectrums 27:2, pages 199-207.
Crossref
Crossref
Di Fu, Dan-Dan Wu, Hong-Li Guo, Ya-Hui Hu, Ying Xia, Xing Ji, Wei-Rong Fang, Yun-Man Li, Jing Xu, Feng Chen & Qian-Qi Liu. (2022) The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review. Frontiers in Psychiatry 12.
Crossref
Crossref
Ahmet Koyuncu, Tuğba Ayan, Ezgi Ince Guliyev, Seda Erbilgin & Erdem Deveci. (2022) ADHD and Anxiety Disorder Comorbidity in Children and Adults: Diagnostic and Therapeutic Challenges. Current Psychiatry Reports 24:2, pages 129-140.
Crossref
Crossref
Madeleine J. Groom & Samuele Cortese. 2022. New Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder. New Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder
19
50
.
Xiaolin Mei, Lutong Wang, Bo Yang & Xinwang Li. (2021) Sex differences in noradrenergic modulation of attention and impulsivity in rats. Psychopharmacology 238:8, pages 2167-2177.
Crossref
Crossref
Nermin M. ShakerYara OsamaDoaa H. BarakatAhmed Adel AbdelgawadKarim Abdel AzizDina Aly El-Gabry. (2021) Atomoxetine in Attention-Deficit/Hyperactivity Disorder in Children With and Without Comorbid Mood Disorders. Journal of Child and Adolescent Psychopharmacology 31:5, pages 332-341.
Crossref
Crossref
Greg W. Mattingly, Joshua Wilson, Leticia Ugarte & Paul Glaser. (2020) Individualization of attention-deficit/hyperactivity disorder treatment: pharmacotherapy considerations by age and co-occurring conditions. CNS Spectrums 26:3, pages 202-221.
Crossref
Crossref
Annet Bluschke, Nicolas Zink, Moritz Mückschel, Veit Roessner & Christian Beste. (2020) A novel approach to intra-individual performance variability in ADHD. European Child & Adolescent Psychiatry 30:5, pages 733-745.
Crossref
Crossref
Luis Núñez-Jaramillo, Andrea Herrera-Solís & Wendy Verónica Herrera-Morales. (2021) ADHD: Reviewing the Causes and Evaluating Solutions. Journal of Personalized Medicine 11:3, pages 166.
Crossref
Crossref
Shamia L. Faison, Nicholas Fry, Toyin Adewole, Oyinkansola Odebo, Stefan Schwabe, Zhao Wang, Vladimir Maletic & Azmi Nasser. (2020) Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults. Clinical Drug Investigation 41:2, pages 149-159.
Crossref
Crossref
Adanna Hackett, Rose Joseph, Kevlin Robinson, Jeremy Welsh, Joyce Nicholas & Eric Schmidt. (2020) Adult attention deficit/hyperactivity disorder in the ambulatory care setting. JAAPA 33:8, pages 12-16.
Crossref
Crossref
Daniela Zmeškalová. (2020) Atomoxetine. Psychiatrie pro praxi 21:1, pages 47-52.
Crossref
Crossref
Gianmaria Zita & Giovanni Migliarese. (2020) La doppia diagnosi ADHD e SUD. MISSION:53, pages 10-16.
Crossref
Crossref
Maik Pertermann, Annet Bluschke, Veit Roessner & Christian Beste. (2019) The Modulation of Neural Noise Underlies the Effectiveness of Methylphenidate Treatment in Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 4:8, pages 743-750.
Crossref
Crossref
Vito Pinzone, Pietro De Rossi, Guido Trabucchi, David Lester, Paolo Girardi & Maurizio Pompili. (2019) Temperament correlates in adult ADHD: A systematic review★★. Journal of Affective Disorders 252, pages 394-403.
Crossref
Crossref
Masanori Ogata, Hisanao Akita & Hitoshi Ishibashi. (2019) Behavioral responses to anxiogenic tasks in young adult rats with neonatal dopamine depletion. Physiology & Behavior 204, pages 10-19.
Crossref
Crossref
Camila B. Villas-Boas, Danielly Chierrito, Fernando Fernandez-Llimos, Fernanda S. Tonin & Andréia C.C. Sanches. (2019) Pharmacological treatment of attention-deficit hyperactivity disorder comorbid with an anxiety disorder. International Clinical Psychopharmacology 34:2, pages 57-64.
Crossref
Crossref
Kelda Harris Walsh, Katherine Soe & Shivali Sarawgi. (2018) Psychiatric Treatment and Management of Psychiatric Comorbidities of Movement Disorders. Seminars in Pediatric Neurology 25, pages 123-135.
Crossref
Crossref
Frederick W. Reimherr, Barrie K. Marchant, Thomas E. Gift & Tammy A. Steans. (2017) ADHD and Anxiety: Clinical Significance and Treatment Implications. Current Psychiatry Reports 19:12.
Crossref
Crossref